
Repligen fell 2.1% from $167.26 to $163.81, behind the S&P 500's +3.2%. Its worst day was Apr 23 (−8.3%), and its low came May 15 at $102.87.
Nov 24, 2025 – Nov 20, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $0.49 beat the $0.44 estimate on $197.9M revenue (est. $192.2M); FY revenue guidance of $810.0M–$840.0M against the $822.8M consensus.
−0.5% · S&P 500 +0.7%
Story events cover the past 12 months · Times ET
Repligen shares fell 8.3%, while the S&P 500 fell 0.4%.
−8.3%, the year's worst day · S&P 500 −0.4%
EPS of $0.48 beat the $0.38 estimate on $194.3M revenue (est. $192.0M); FY revenue guidance of $803.0M–$833.0M against the $827.9M consensus.
+6.3% · S&P 500 +0.8%
Repligen closed at its lowest level of the year, 38.5% below where the year started.
−0.5% · S&P 500 −1.2%
Repligen shares rose 8.4%, while the S&P 500 rose 0.6%.
+8.4% · S&P 500 +0.6%
Repligen shares rose 9.5%, while the S&P 500 fell 0.0%.
+9.5% · S&P 500 0.0%
EPS of $0.54 beat the $0.45 estimate on $204.1M revenue (est. $201.2M); FY revenue guidance of $813.0M–$835.0M against the $819.5M consensus.
+10.9%, the year's best day · S&P 500 +0.2%
Repligen closed at its highest level of the year, 16.3% above where the year started.
+0.2% · S&P 500 −0.2%
EPS of $0.53 beat the $0.46 estimate on $209.3M revenue (est. $206.7M); FY revenue guidance of $844.0M–$852.0M against the $834.1M consensus.
−2.4% · S&P 500 +0.6%
Where it ended: a close of $163.81 on Nov 20, 2026. Up next: Q4 2026 earnings on Feb 23, 2027 (EPS est. $0.52, revenue est. $241.1M).
Nothing in the past 12 months.
All RGEN dividend historyReplay the year: the line draws itself and stops at each of the 9 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for RGEN and SPY from Benzinga historical bars. Not investment advice.